A protective role for HIF-1 in response to redox manipulation and glucose deprivation: implications for tumorigenesis
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
We have investigated the role of HIF-1 in the cellular response to redox modulation via the inhibition of oxidative phosphorylation. We demonstrate that manipulation of redox in air, achieved by inhibiting cytochrome oxidase with cyanide, induces HIF-1 mediated transcription in wild-type CHO and HT1080 human tumour cells but not in CHO cells deficient in the oxygen responsive, HIF-1alpha sub-unit of HIF-1. Hypoglycaemia attenuates cyanide-mediated transcription in non-transformed HIF-1 wild-type CHO cells but not the human tumour derived cell line. Cells lacking either HIF-1alpha, or the second composite sub-unit of HIF-1, HIF-1beta, were markedly more sensitive to the combined stress of perturbed redox and hypoglycaemia than wild-type cells. As such conditions together with hypoxia are prevalent in tumours, these data suggest that HIF-1 may have a protective role in adaptation to the tumour micro-environment. In support of this we demonstrate that HIF-1alpha deficient cells are less tumorigenic than wild-type cells. They showed a reduced growth rate when grown as xenografts in nude mice. This was not related to vascular parameters that were identical to those found in HIF-1 wild-type tumours. The HIF-1 deficient tumours lacked focal expression of Glut-1 in hypoxic tumour regions. Compromised glucose uptake and metabolic adaptation to the tumour micro-environment may form the basis of the reduced tumorigenicity associated with these cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several preclinical models of HIF-1-deficient tumours initially undergo a period of slow growth before subsequently demonstrating accelerated growth, suggesting the development of resistance and escape mechanisms from the inhibition of HIF-1 [13,14,15,16].”
From HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells (2021) · cites this paper as [14]
In the citing paper
“there is evidence that hypoxic cancer cells can adapt metabolically to HIF-1 inhibition, which would provide a potential route for drug resistance.”
From HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells (2021) · cites this paper as [14]
In the citing paper
“Hepa-1 c4 cells are deficient in the HIF-1β subunit, which is an essential component of both the HIF-1 and HIF-2 active complexes, so they cannot form functional HIF-1 or HIF-2 (HIF-1/2) dimeric complexes or activate HIF-1/2-dependent gene transcription [13,14,15,16,29,56].”
From HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells (2021) · cites this paper as [14]
Citations
Cites
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535 · cited 2×
“More recently, targeted degradation of the HIF-1a subunit of HIF-1 under aerobic conditions has been shown to be dependent on proline hydroxylation (Ivan et al., 2001; Jaakkola et al., 2001).”
BackgroundHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 2×
“More recently, targeted degradation of the HIF-1a subunit of HIF-1 under aerobic conditions has been shown to be dependent on proline hydroxylation (Ivan et al., 2001; Jaakkola et al., 2001).”
BackgroundRole of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502 · cited 2×
“Murine embryonic stem (ES) cells engineered to lack HIF-1a expression reveal con¯icting data regarding the contribution of HIF-1a to tumour growth (Carmeliet et al., 1998; Ryan et al., 1998).”
BackgroundChandel, N. S., McClintock, D. S., Feliciano, C. E., Wood, T. M., Melendez, J. A., Rodriguez, A. M., & Schumacker, P. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001914200 · Cited by 2,000 · cited 5×
“Perturbed mitochondrial redox and concomitant generation of reactive oxygen species (ROS) at complex III have recently been implicated as a mechanism of HIF-1a stabilisation (Chandel et al., 2000).”
BackgroundResultInfluentialMitochondrial reactive oxygen species trigger hypoxia-induced transcription
Chandel, N. S., Maltepe, E., Goldwasser, E., Mathieu, C. E., Simon, M. C., & Schumacker, P. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11715 · Cited by 1,926 · cited 3×
“Perturbations of the mitochondrial respiratory chain under hypoxia have been implicated (Chandel et al., 1998, 2000; Agani et al., 2000).”
BackgroundResultHIF‐1α is required for solid tumor formation and embryonic vascularization
Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579 · cited 2×
“Murine embryonic stem (ES) cells engineered to lack HIF-1a expression reveal con¯icting data regarding the contribution of HIF-1a to tumour growth (Carmeliet et al., 1998; Ryan et al., 1998).”
BackgroundTian, H., McKnight, S. L., & Russell, D. W. (1997) · Genes & Development · doi:10.1101/gad.11.1.72 · Cited by 1,351 · cited 1×
“5 strains were derived from Chinese Hamster Ovary (CHO) cells that lack expression of the HIF-2a protein (EPAS; Tian et al., 1997) which shows high sequence homology to HIF-1a and can similarly complex with HIF-1b to initiate HREmediated transcription.”
MethodMaxwell, P. H., Dachs, G. U., Gleadle, J. M., Nicholls, L. G., Harris, A. L., Stratford, I. J., Hankinson, O., Pugh, C. W., & Ratcliffe, P. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8104 · Cited by 1,084 · cited 1×
“More consistent data have been reported using xenografts derived from HIF-1b de®cient cells, which have been repeatedly shown to be less tumorigenic than the parental strain, Hepa-1 wt, (Jiang et al., 1997; Maxwell et al., 1997; Stratford et al., 1999).”
MethodSelf-citationHypoxia-inducible factor-1alpha is a positive factor in solid tumor growth.
Ryan, H. E., Poloni, M., McNulty, W., Elson, D., Gassmann, M., Arbeit, J. M., & Johnson, R. S. (2000) · PubMed · Cited by 888
(2000) · PubMed · Cited by 614
Jiang, B., Agani, F. H., Passaniti, A., & Semenza, G. L. (1997) · PubMed · Cited by 603
Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha /ARNT
Zelzer, E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5085 · Cited by 575 · cited 1×
“…has a core consensus sequence (CACGTG) that overlaps that of the HIF-1 binding site (CGTG, Dang et al., 1997) and that the induction of glycolytic enzymes in response to insulin, which would be related to a `high glucose' condition, has been shown to be HIF-1 dependent (Zelzer et al., 1998).”
BackgroundTeicher, B. A. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00689633 · Cited by 563 · cited 1×
“Hypoxia is a common environmental stress prevailing in tumours and is associated with poor therapeutic outcome (reviewed in Teicher, 1994).”
BackgroundOxygen Sensing, Hypoxia-Inducible Factor-1 and the Regulation of Mammalian Gene Expression
Ratcliffe, P. J., O’rourke, J. F., Maxwell, P. H., & Pugh, C. W. (1998) · Journal of Experimental Biology · doi:10.1242/jeb.201.8.1153 · Cited by 371
Targeting gene expression to hypoxic tumor cells
Dachs, G. U., Patterson, A. V., Firth, J. D., Ratcliffe, P. J., Townsend, K. M. S., Stratford, I. J., & Harris, A. L. (1997) · Nature Medicine · doi:10.1038/nm0597-515 · Cited by 368 · cited 3×
“…KJ Williams; E-mail: kaye.williams@man.ac.uk Received 6 March 2001; revised 28 September 2001; accepted 9 October 2001 ments were carried out using a transfected human tumour cell line (Dachs et al., 1997) and a HIF-1b de®cient hepatoma model (Wood et al., 1996).”
BackgroundMethodResultInfluentialSelf-citationAirley, R. E., Loncaster, J. A., Davidson, S. E., Bromley, M., Roberts, S. K., Patterson, A. V., Hunter, R. D., Stratford, I. J., & West, C. (2001) · PubMed · Cited by 361
Self-citationRaleigh, J. A., Chou, S.-C., Arteel, G. E., & Horsman, M. R. (1999) · Radiation Research · doi:10.2307/3580034 · Cited by 304 · cited 1×
“In the wt tumours, Glut-1 staining was apparent in the tumour regions bordering necrosis, and co-localized with staining for the hypoxic marker, pimonidazole (1-[(2-hydroxy-3piperidinyl)propyl]-2-nitroimidazole hydrochloride (Raleigh et al., 1999); Figure 6a,c,e).”
BackgroundWood, S. M., Gleadle, J. M., Pugh, C. W., Hankinson, O., & Ratcliffe, P. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.15117 · Cited by 292 · cited 2×
“…KJ Williams; E-mail: kaye.williams@man.ac.uk Received 6 March 2001; revised 28 September 2001; accepted 9 October 2001 ments were carried out using a transfected human tumour cell line (Dachs et al., 1997) and a HIF-1b de®cient hepatoma model (Wood et al., 1996).”
MethodIncreased expression of hypoxia inducible factor-1alpha in rat and human prostate cancer.
Zhong, H., Agani, F. H., Baccala, A. A., Laughner, E., Rioseco‐Camacho, N., Wb, I., Simons, J. W., & Semenza, G. L. (1998) · PubMed · Cited by 255
Blancher, C., Moore, J. W., Talks, K., Houlbrook, S., & Harris, A. L. (2000) · PubMed · Cited by 255
Self-citationPugh, C. W., Tan, C. C., Jones, R. W., & Ratcliffe, P. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10553 · Cited by 254 · cited 1×
“…cyanide elicited a stronger response Oncogene through the PGK-1-HRE sequence than that seen from the EPO-HRE which may explain why cyanide was shown not to regulate EPO expression in previous studies using di erent systems (Necas and Thornling, 1972; Pugh et al., 1991; Tan and Ratcli e, 1991).”
ResultThe Role of Mitochondria in the Regulation of Hypoxia-inducible Factor 1 Expression during Hypoxia
Agani, F. H., Pichiule, P., Chavez, J. C., & LaManna, J. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005643200 · Cited by 210 · cited 2×
“Perturbations of the mitochondrial respiratory chain under hypoxia have been implicated (Chandel et al., 1998, 2000; Agani et al., 2000).”
BackgroundResultWood, S. M., Wiesener, M. S., Yeates, K. M., Okada, N., Pugh, C. W., Maxwell, P. H., & Ratcliffe, P. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.14.8360 · Cited by 193 · cited 5×
“We used HIF-1 wild-type (wt) and HIF-1a de®cient Chinese hamster ovary (CHO) cells (Wood et al., 1998) transfected with marker constructs for HRE mediated transcription to evaluate the e ect of cyanide and associated alterations in mitochondrial redox on HIF-1 transactivation.”
BackgroundMethodResultInfluentialBehrooz, A., & Ismail-Beigi, F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5555 · Cited by 167 · cited 1×
“Glut-1 is induced both by hypoxia and inhibition of oxidative phosphorylation in vitro (Behrooz and Ismail-Beigi, 1997).”
BackgroundSrinivas, V., Leshchinsky, I., Sang, N., King, M. P., Minchenko, A., & Caro, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100177200 · Cited by 143 · cited 2×
“This may be the basis for why HIF-1 has been shown to be unresponsive to rotenone exposure in the present study, and why rotenone ablates the hypoxic response in others (Chandel et al., 1998, 2000; Srinivas et al., 2001).”
BackgroundResultOncogenes in Tumor Metabolism, Tumorigenesis, and Apoptosis
Dang, C. V., Lewis, B. C., Dolde, C. E., Dang, G., & Shim, H. (1997) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1022446730452 · Cited by 127 · cited 2×
“…(ChoRE), found upstream of many glycolytic enzymes, has a core consensus sequence (CACGTG) that overlaps that of the HIF-1 binding site (CGTG, Dang et al., 1997) and that the induction of glycolytic enzymes in response to insulin, which would be related to a `high glucose' condition, has…”
BackgroundHodgkiss, R. J., Jones, G., Long, A., PARRICK, J., Smith, K., Stratford, M., & Wilson, G. D. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.24 · Cited by 73 · cited 1×
“In addition, no di erences were apparent between the tumour types in the relative tumour area binding the bioreductive hypoxic marker, NITP (7-(4-(2- nitroimidazole-l-yl)-butyl)-theophylline (Hodgkiss et al., 1991); see Figure 5, green signal and Table 1.”
BackgroundMultiparameter analysis of vasculature, perfusion and proliferation in human tumour xenografts
Bussink, J., Kaanders, J. H. A. M., Rijken, P. F. J. W., Martindale, C. A., & van der Kogel, A. J. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.9 · Cited by 73 · cited 1×
“…fraction in the CHO xenograft models The immunohistochemical staining, image analysis and quantitative procedures allowing simultaneous evaluation of vessel density and hypoxic fraction (NITP incorporation) on a single tumour section have been extensively described elsewhere (Bussink et al., 1998).”
MethodUnresponsiveness of erythropoietin-producing cells to cyanide
Nečas, E., & Thorling, E. B. (1972) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1972.222.5.1187 · Cited by 33
Tan, C. C., & Ratcliffe, P. J. (1991) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1991.261.6.f982 · Cited by 30
Noise level of drilling instruments during mastoidectomy
Lee, H. K., Lee, E. H., Choi, J. Y., Choi, H. S., & Kim, H. N. (1999) · Yonsei Medical Journal · doi:10.3349/ymj.1999.40.4.339 · Cited by 23
Tumour hypoxia pathophysiology, clinical significance and therapeutic perspectives
Huilgol, N. (2005) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.19606 · Cited by 16
Research works printed but not linked: 1
- Griffiths JR, McSheehy PMJ, Robinson SP, Troy H, Chung Y-L, Jackson D, Williams KJ, Stratford IJ, Stubbs M . Cancer Res. in press
Cited by
Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors
Haddad, J. J. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(02)00053-0 · Cited by 427
Erler, J. T., Cawthorne, C. J., Williams, K. J., Koritzinsky, M., Wouters, B. G., Wilson, C., Miller, C., Demonacos, C., Stratford, I. J., & Dive, C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.7.2875-2889.2004 · Cited by 400
“assays or into 6-well plates for clonogenic assays as previously described (54).”
BackgroundMethodSelf-citationHyperglycemia Regulates Hypoxia-Inducible Factor-1α Protein Stability and Function
Catrina, S.-B., Okamoto, K., Pereira, T., Brismar, K., & Poellinger, L. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3226 · Cited by 384
Airley, R. E., & Mobasheri, A. (2007) · Chemotherapy · doi:10.1159/000104457 · Cited by 342
Self-citationThe hypoxia-inducible factor-1α is a negative factor for tumor therapy
Unruh, A., Ressel, A., Mohamed, H. G., Johnson, R. S., Nadrowitz, R., Richter, E., Katschinski, D. M., & Wenger, R. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206385 · Cited by 334
“…6Present address; Cell Physiology Group, Medical Faculty, MartinLuther-University Halle, D-06112 Halle, Germany Oncogene (2003) 22, 3213–3220 & 2003 Nature Publishing Group All rights reserved 0950-9232/03 $25.00 www.nature.com/onc Williams et al., 2002) are positive factors for solid tumor growth.”
BackgroundInfluential
Metadata
- Authors
- Williams, K. J., Telfer, B. A., Airley, R. E., Peters, H. P., Sheridan, M. R., van der Kogel, A. J., Harris, A. L., & Stratford, I. J.
- Affiliations
- University of Manchester (GB)
- The Christie Hospital (GB)
- Radboud University Nijmegen (NL)
- John Radcliffe Hospital (GB)
- Corresponding author
- Williams, Kaye J
- Venue
- Oncogene
- Published
- 2002-01-10
- Volume
- 21
- Issue
- 2
- Pages
- 282-290
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2137661415
- Cited by
- 81
- References
- 32
- Citations by year
- 2024: 2 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 1 · 2019: 2 · 2018: 2 · 2016: 1 · 2015: 1 · 2014: 3 · 2013: 1 · 2012: 3
- FWCI
- 5.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- University of Huddersfield Repository (University of Huddersfield) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- HIF-1, HIF-1α, ARNT, redox regulation, oxidative phosphorylation inhibition, cyanide, hypoglycemia, glucose deprivation, tumorigenicity, tumor microenvironment, hypoxia, glucose transporter 1, xenograft tumor growth, tumor glucose metabolism
- MeSH terms
- Animals, Cell Survival, Cell Transformation, Neoplastic, DNA-Binding Proteins, Female, Fibrosarcoma, Glucose, Cricetinae, Humans, Hypoglycemia, Mice, Nude, Monosaccharide Transport Proteins, Neovascularization, Pathologic, Nuclear Proteins, Oxidation-Reduction, Transcription Factors, Transplantation, Heterologous, Tumor Cells, Cultured, Mutagenesis, CHO Cells, Glucose Transporter Type 1, Mice, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.